Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Atassi

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Experimental antitumour activity of S 16020-2 in a panel of human tumoursL Kraus-Berthier, N Guilbaud, M Jan, et al.
Anti-Cancer Drug Design|March 1, 1989
Nucleoside analogues: 7. Effect on colon, breast and lung tumours in mice of 5-fluorouracil/nitrosourea molecular combinations incorporating alkoxy and oxidized sulphur functionsR S McElhinney, J E McCormick, M C Bibby, et al.
Journal of Medicinal Chemistry|January 1, 1991
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedioneS Giorgi-Renault, J Renault, P Gebel-Servolles, et al.
Archiv Der Pharmazie|February 1, 1989
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl) ethylenediamine]dichloroplatinum(II)-complexes, Part II: Biological propertiesM Jennerwein, R Gust, R Müller, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivativesP Lelieveld, W J Van der Vijgh, R W Veldhuizen, et al.
Anti-Cancer Drugs|December 13, 1997
Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivoA D Morris, S Léonce, N Guilbaud, et al.
Archiv Der Pharmazie|January 1, 1989
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]dichloroplatinum(II)-compl exe s, Part I: SynthesisM Jennerwein, R Gust, R Müller, et al.
Chemical & Pharmaceutical Bulletin|November 1, 1996
Synthesis and biological evaluation of 6-(9-hydroxy-5-methyl (and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazol-1-yl)picolinic amides as new olivacine derivativesC Landras, R Jasztold-Howorko, A Pierré, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1989
Human medullary thyroid carcinoma: cell cultures and xenotransplants in nude mice. Immunocytochemistry and calcitonin secretionG Andry, P Lothaire, P Vico, et al.
Cancer Treatment Reports|November 1, 1983
Iv administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to manA Coune, J P Sculier, J Frühling, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Experimental antitumour activity of S 16020-2 in a panel of human tumoursL Kraus-Berthier, N Guilbaud, M Jan, et al.
Anti-Cancer Drug Design|March 1, 1989
Nucleoside analogues: 7. Effect on colon, breast and lung tumours in mice of 5-fluorouracil/nitrosourea molecular combinations incorporating alkoxy and oxidized sulphur functionsR S McElhinney, J E McCormick, M C Bibby, et al.
Journal of Medicinal Chemistry|January 1, 1991
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedioneS Giorgi-Renault, J Renault, P Gebel-Servolles, et al.
Archiv Der Pharmazie|February 1, 1989
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl) ethylenediamine]dichloroplatinum(II)-complexes, Part II: Biological propertiesM Jennerwein, R Gust, R Müller, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivativesP Lelieveld, W J Van der Vijgh, R W Veldhuizen, et al.
Anti-Cancer Drugs|December 13, 1997
Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivoA D Morris, S Léonce, N Guilbaud, et al.
Archiv Der Pharmazie|January 1, 1989
Tumor inhibiting properties of stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine]dichloroplatinum(II)-compl exe s, Part I: SynthesisM Jennerwein, R Gust, R Müller, et al.
Chemical & Pharmaceutical Bulletin|November 1, 1996
Synthesis and biological evaluation of 6-(9-hydroxy-5-methyl (and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazol-1-yl)picolinic amides as new olivacine derivativesC Landras, R Jasztold-Howorko, A Pierré, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1989
Human medullary thyroid carcinoma: cell cultures and xenotransplants in nude mice. Immunocytochemistry and calcitonin secretionG Andry, P Lothaire, P Vico, et al.
Cancer Treatment Reports|November 1, 1983
Iv administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to manA Coune, J P Sculier, J Frühling, et al.
Pageof 19